{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:25:46Z","timestamp":1788492346522,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.euroneuro.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:49:11Z","timestamp":1617410951000},"page":"39-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site"],"prefix":"10.1016","volume":"45","author":[{"given":"Tatiana","family":"Borisova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pozdnyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Dudarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Krisanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Andronati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2021.03.013_bib0001","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF02465736","article-title":"Bioaccessibility of cinazepam introduced as inclusion complex with \u03b2-cyclodextrin","volume":"32","author":"Andronati","year":"1998","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0002","unstructured":"Andronati, S.A., Yakubovska, L.M., Yavorskyi, O.S., Pavlovskii, V.I., Holovenko, M.Y., Sieredenin, S.B., Voronina, T.A., Molodavkin, H.M., Haribova, T.L., Bliednov, Y.O., Liubimov, B.I., Piatin, B.M., Vyrovschykova, S.M., Bitienskyi, V.S., Hordei, M.L., 1997. Starwriter 3-oxy-7-brom-5-(ortho-chlor)phenyl1,2-dihydro-3h-1,4-benzdiazepine-2-one hemisuccinate having hypnogenic, sedative, tranquilizing activity [WWW Document]. Pat. Ukr. 19803, A61P 25\/20, A61K 31\/5513, A61P 25\/22, C07D 243\/18. URL http:\/\/uapatents.com\/11-19803-gemisukcinat-3-oksi-7-brom-5-orto-khlor-fenil12-digidro-3n-14-benzdi-azepin-2-ona-shho-maeh-snotvornu-sedativnu-trankvilizuyuchu-aktivnist.html (accessed 8.21.19)."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0003","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1038\/s41598-017-03154-5","article-title":"Differential depression of neuronal network activity by midazolam and its main metabolite 1-hydroxymidazolam in cultured neocortical slices","volume":"7","author":"Balk","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41526-019-0062-7","article-title":"Perspective express assessment of neurotoxicity of particles of planetary and interstellar dust","volume":"5","author":"Borisova","year":"2019","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0005","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3389\/fphys.2018.00728","article-title":"Nervous system injury in response to contact with environmental, engineered and planetary micro- and nano-sized particles","volume":"9","author":"Borisova","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/revneuro-2015-0023","article-title":"Permanent dynamic transporter-mediated turnover of glutamate across the plasma membrane of presynaptic nerve terminals: arguments in favor and against","volume":"27","author":"Borisova","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0007","first-page":"89","article-title":"The neurotoxic effects of heavy metals: alterations in acidification of synaptic vesicles and glutamate transport in brain nerve terminals","author":"Borisova","year":"2014","journal-title":"Horizons Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0008","series-title":"Cholesterol and Presynaptic Glutamate Transport in the Brain, SpringerBriefs in Neuroscience","author":"Borisova","year":"2013"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/revneuro-2015-0044","article-title":"Putative duality of presynaptic events","volume":"27","author":"Borisova","year":"2016","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10571-015-0321-4","article-title":"Dynamic gradient of glutamate across the membrane: glutamate\/aspartate-induced changes in the ambient level of L-[(14)C]glutamate and D-[(3)H]aspartate in rat brain nerve terminals","volume":"36","author":"Borisova","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0011","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bmc.2016.11.052","article-title":"Effects of new fluorinated analogues of GABA, pregabalin bioisosters, on the ambient level and exocytotic release of [(3)H]GABA from rat brain nerve terminals","volume":"25","author":"Borisova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0012","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.bmc.2015.06.038","article-title":"Synthesis of new fluorinated analogs of GABA, Pregabalin bioisosteres, and their effects on [(3)H]GABA uptake by rat brain nerve terminals","volume":"23","author":"Borisova","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0013","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3325\/cmj.2014.55.195","article-title":"A comparative study of neurotoxic potential of synthesized polysaccharide-coated and native ferritin-based magnetic nanoparticles","volume":"55","author":"Borysov","year":"2014","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114502","article-title":"Plastic smoke aerosol: nano-sized particle distribution, absorption\/fluorescent properties, dysregulation of oxidative processes and synaptic transmission in rat brain nerve terminals","volume":"263","author":"Borysov","year":"2020","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","article-title":"New benzodiazepines for sedation","volume":"32","author":"Cornett","year":"2018","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0076-6879(74)31050-6","article-title":"Isolation of synaptosomal and synaptic plasma membrane fractions","volume":"31","author":"Cotman","year":"1974","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0017","first-page":"129","article-title":"Animal techniques for evaluating benzodiazepine drugs","volume":"1","author":"de Angelis","year":"1979","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0018","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/ANE.0b013e3181f9c035","article-title":"Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms","volume":"111","author":"Drexler","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0019","doi-asserted-by":"crossref","unstructured":"Fung, S.C., Fillenz, M., 1983. The role of pre-synaptic GABA and benzodiaFung, S.C., Fillenz, M., 1983. The role of pre-synaptic GABA and benzodiazepine receptors in the control of noradrenaline release in rat hippocampus. Neurosci. Lett. 42, 61\u201366. doi:10.1016\/0304-3940(83)90422-6.","DOI":"10.1016\/0304-3940(83)90422-6"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0020","first-page":"22","article-title":"Influence of cinazepam on sleep-wake up cycle in rats (Russian) [WWW Document]","volume":"2","author":"Godlevsky","year":"2005","journal-title":"Prog. Biol. Med."},{"issue":"8","key":"10.1016\/j.euroneuro.2021.03.013_bib0021","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/ijms18081813","article-title":"Towards a better understanding of GABAergic remodeling in Alzheimer's disease","volume":"18","author":"Govindpani","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0022","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.2011.01228.x","article-title":"Flavonoid modulation of GABA(A) receptors","volume":"163","author":"Hanrahan","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0023","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s002130050007","article-title":"Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers","volume":"147","author":"Hemmeter","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0024","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12023","article-title":"Benzodiazepine dependence and its treatment with low dose flumazenil","volume":"77","author":"Hood","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0025","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1152\/jn.00779.2018","article-title":"Direction of action of presynaptic GABAA receptors is highly dependent on the level of receptor activation","volume":"121","author":"Khatri","year":"2019","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbiomolbio.2004.06.003","article-title":"Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why?","volume":"87","author":"Kullmann","year":"2005","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0027","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0028","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0003-2697(86)90432-X","article-title":"Artificial reductant enhancement of the Lowry method for protein determination","volume":"155","author":"Larson","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0029","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/jpet.111.191189","article-title":"\u03c3-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings","volume":"341","author":"Lu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0031","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pharmthera.2009.11.007","article-title":"Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs","volume":"125","author":"Madsen","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0032","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11094-007-0055-9","article-title":"Effect of cinazepam administration on the ligand affinity of neuromediator system receptors in rat brain","volume":"41","author":"Makan","year":"2007","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0033","unstructured":"Maykova, A.V., Zhuk, O.V., 2005. Anticonvulsant Activity of Cinazepam on the Model Seizures with Different Mechanism of Forming (Russian) [WWW Document]. Bull Odessa Nat Univ. URL https:\/\/www.researchgate.net\/publication\/290159516_Anticonvulsant_activity_of_cinazepam_on_the_model_seizures_with_different_mechanism_of_forming_Russian (accessed 8.29.19)."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0034","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0035","doi-asserted-by":"crossref","unstructured":"M\u00f6hler, H., 2015. The Legacy of the Benzodiazepine Receptor, in: Advances in Pharmacology (San Diego, Calif.). pp. 1\u201336. doi:10.1016\/bs.apha.2014.10.008","DOI":"10.1016\/bs.apha.2014.10.008"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0036","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABAA receptor diversity and pharmacology","volume":"326","author":"M\u00f6hler","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12630-010-9429-7","article-title":"GABAA receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation","volume":"58","author":"Olsen","year":"2011","journal-title":"Can. J. Anesth.\/Can. d'anesth."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0038","unstructured":"Onufrienko, O.V., 2012. Neurotropic activity of novel 3-acyloxy-1,2-dihydro-3H-1,4- benzodiazepine-2-ones (Ukrainian), Degree: PhD, Pharmacology, Odessa National Medical University. http:\/\/repo.odmu.edu.ua\/xmlui\/handle\/123456789\/1151?show=full&locale-attribute=en."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0039","unstructured":"Pavlovskii, V., Reder, A., Stelmakh, I., Lempart, H., Andronati, S., 2003. A process for preparing hemisuccinate 3-hydroxy-7-bromine-5-(ortho-chloro)phenyl-1,2-dihydro-3\u043d-1,4-benzdiazepine-2-on, [WWW Document]. Pat. Ukr. 60361, C07D 243\/24, C07D 243\/26, A61K 31\/551, C07D 243\/14. URL http:\/\/uapatents.com\/3-60361-sposib-oderzhannya-gemisukcinatu-3-gidroksi-7-brom-5-orto-khlor-fenil-12-digidro-3n-14-benzdiazepin-2-onu.html (accessed 8.21.19)."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0040","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1523\/JNEUROSCI.19-14-05861.1999","article-title":"Ca(2+)-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons","volume":"19","author":"Perkinton","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijdevneu.2017.09.002","article-title":"Consequences of perinatal hypoxia in developing brain: changes in GABA transporter functioning in cortical, hippocampal and thalamic rat nerve terminals","volume":"63","author":"Pozdnyakova","year":"2017","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0042","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10571-019-00676-6","article-title":"Age-dependency of levetiracetam effects on exocytotic GABA release from nerve terminals in the hippocampus and cortex in norm and after perinatal hypoxia","volume":"39","author":"Pozdnyakova","year":"2019","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0043","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2015.07.037","article-title":"New effects of GABAB receptor allosteric modulator rac-BHFF on ambient GABA, uptake\/release, Em and synaptic vesicle acidification in nerve terminals","volume":"304","author":"Pozdnyakova","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0044","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3325\/cmj.2014.55.250","article-title":"Perinatal hypoxia: different effects of the inhibitors of GABA transporters GAT1 and GAT3 on the initial velocity of [3H]GABA uptake by cortical, hippocampal, and thalamic nerve terminals","volume":"55","author":"Pozdnyakova","year":"2014","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113434","article-title":"Inhibition of sigma-1 receptors substantially modulates GABA and glutamate transport in presynaptic nerve terminals","volume":"333","author":"Pozdnyakova","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0046","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-016-0176-y","article-title":"Neuroactivity of detonation nanodiamonds: dose-dependent changes in transporter-mediated uptake and ambient level of excitatory\/inhibitory neurotransmitters in brain nerve terminals","volume":"14","author":"Pozdnyakova","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0047","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1734-1140(11)70628-4","article-title":"Elimination kinetics of the novel prodrug cinazepam possessing psychotropic activity in mice","volume":"63","author":"Schukin","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0048","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156802611794863562","article-title":"A closer look at the high affinity benzodiazepine binding site on GABAA receptors","volume":"11","author":"Sigel","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0049","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.neuro.26.041002.131412","article-title":"The synaptic vesicle cycle","volume":"27","author":"Sudhof","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/35079084","article-title":"Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse","volume":"411","author":"Turecek","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0051","series-title":"The Oxford Handbook of Neuronal Ion Channels","article-title":"GABAA receptor physiology and pharmacology","author":"Wallner","year":"2018"},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0052","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0053","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.phrs.2015.12.011","article-title":"Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development","volume":"104","author":"Zaccara","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0054","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fchem.2018.00397","article-title":"Structure, function, and modulation of \u03b3-aminobutyric acid transporter 1 (GAT1) in neurological disorders: a pharmacoinformatic prospective","volume":"6","author":"Zafar","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.euroneuro.2021.03.013_bib0055","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1113\/JP275369","article-title":"Axonal GABAA receptors depolarize presynaptic terminals and facilitate transmitter release in cerebellar Purkinje cells","volume":"595","author":"Zorrilla de San Martin","year":"2017","journal-title":"J. Physiol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2100167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X2100167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:58:39Z","timestamp":1760378319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X2100167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"alternative-id":["S0924977X2100167X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.03.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}